Literature DB >> 15271902

The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139.

Muhammad Asaduzzaman1, Edward T Ryan, Manohar John, Long Hang, Ashraful I Khan, A S G Faruque, Ronald K Taylor, Stephen B Calderwood, Firdausi Qadri.   

Abstract

Diarrhea caused by Vibrio cholerae is known to give long-lasting protection against subsequent life-threatening illness. The serum vibriocidal antibody response has been well studied and has been shown to correlate with protection. However, this systemic antibody response may be a surrogate marker for mucosal immune responses to key colonization factors of this organism, such as the toxin-coregulated pilus (TCP) and other factors. Information regarding immune responses to TCP, particularly mucosal immune responses, is lacking, particularly for patients infected with the El Tor biotype of V. cholerae O1 or V. cholerae O139 since highly purified TcpA from these strains has not been available previously for use in immune assays. We studied the immune responses to El Tor TcpA in cholera patients in Bangladesh. Patients had substantial and significant increases in TcpA-specific antibody-secreting cells in the circulation on day 7 after the onset of illness, as well as similar mucosal responses as determined by an alternate technique, the assay for antibody in lymphocyte supernatant. Significant increases in antibodies to TcpA were also seen in sera and feces of patients on days 7 and 21 after the onset of infection. Overall, 93% of the patients showed a TcpA-specific response in at least one of the specimens compared with the results obtained on day 2 and with healthy controls. These results demonstrate that TcpA is immunogenic following natural V. cholerae infection and suggest that immune responses to this antigen should be evaluated for potential protection against subsequent life-threatening illness.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15271902      PMCID: PMC470637          DOI: 10.1128/IAI.72.8.4448-4454.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera.

Authors:  F Qadri; F Ahmed; M M Karim; C Wenneras; Y A Begum; M Abdus Salam; M J Albert; J R McGhee
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

2.  A serological survey for cholear antibodies in rural east Pakistan. 1. The distribution of antibody in the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera.

Authors:  W H Mosley; A S Benenson; R Barui
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

3.  Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1.

Authors:  F Qadri; C Wennerås; M J Albert; J Hossain; K Mannoor; Y A Begum; G Mohi; M A Salam; R B Sack; A M Svennerholm
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

4.  Detection of antibodies to toxin-coregulated pili in sera from cholera patients.

Authors:  Stephen R Attridge; Gun Wallerström; Firdausi Qadri; Ann-Mari Svennerholm
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

5.  Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers.

Authors:  Firdausi Qadri; Edward T Ryan; A S G Faruque; Firoz Ahmed; Ashraful Islam Khan; M Monirul Islam; Syed M Akramuzzaman; David A Sack; Stephen B Calderwood
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

6.  Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18-36 months of age.

Authors:  Firdausi Qadri; Tanvir Ahmed; Firoz Ahmed; R Bradley Sack; David A Sack; Ann Mari Svennerholm
Journal:  Vaccine       Date:  2003-06-02       Impact factor: 3.641

7.  Type IV pilin structure and assembly: X-ray and EM analyses of Vibrio cholerae toxin-coregulated pilus and Pseudomonas aeruginosa PAK pilin.

Authors:  Lisa Craig; Ronald K Taylor; Michael E Pique; Brian D Adair; Andrew S Arvai; Mona Singh; Sarah J Lloyd; David S Shin; Elizabeth D Getzoff; Mark Yeager; Katrina T Forest; John A Tainer
Journal:  Mol Cell       Date:  2003-05       Impact factor: 17.970

8.  Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh.

Authors:  Debasish Saha; Regina C LaRocque; Ashraful I Khan; Jason B Harris; Yasmin Ara Begum; Syed M Akramuzzaman; Abu S G Faruque; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  J Infect Dis       Date:  2004-05-25       Impact factor: 5.226

9.  The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients.

Authors:  W H Mosley; S Ahmad; A S Benenson; A Ahmed
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

10.  Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio cholerae.

Authors:  Long Hang; Manohar John; Muhammad Asaduzzaman; Emily Anna Bridges; Cecily Vanderspurt; Thomas J Kirn; Ronald K Taylor; Jeffrey D Hillman; Ann Progulske-Fox; Martin Handfield; Edward T Ryan; Stephen B Calderwood
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-25       Impact factor: 12.779

View more
  24 in total

1.  Transcriptional profiling of Vibrio cholerae recovered directly from patient specimens during early and late stages of human infection.

Authors:  Regina C Larocque; Jason B Harris; Michelle Dziejman; Xiaoman Li; Ashraful I Khan; Abu S G Faruque; Shah M Faruque; G B Nair; Edward T Ryan; Firdausi Qadri; John J Mekalanos; Stephen B Calderwood
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae.

Authors:  Leslie M Mayo-Smith; Jakub K Simon; Wilbur H Chen; Douglas Haney; Michael Lock; Caroline E Lyon; Stephen B Calderwood; Beth D Kirkpatrick; Mitchell Cohen; Myron M Levine; Marc Gurwith; Jason B Harris
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

Review 3.  Immunology of gut mucosal vaccines.

Authors:  Marcela F Pasetti; Jakub K Simon; Marcelo B Sztein; Myron M Levine
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

4.  Cholera caused by Vibrio cholerae O1 induces T-cell responses in the circulation.

Authors:  Taufiqur Rahman Bhuiyan; Samuel B Lundin; Ashraful Islam Khan; Anna Lundgren; Jason B Harris; Stephen B Calderwood; Firdausi Qadri
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

5.  Cholera in pregnancy: Clinical and immunological aspects.

Authors:  Ashraful I Khan; Fahima Chowdhury; Daniel T Leung; Regina C Larocque; Jason B Harris; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri
Journal:  Int J Infect Dis       Date:  2015-08-14       Impact factor: 3.623

6.  Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice.

Authors:  Stefan Schild; Eric J Nelson; Andrew Camilli
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

7.  Comparison of clinical features and immunological parameters of patients with dehydrating diarrhoea infected with Inaba or Ogawa serotypes of Vibrio cholerae O1.

Authors:  Ashraful I Khan; Fahima Chowdhury; Jason B Harris; Regina C Larocque; Abu S G Faruque; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri
Journal:  Scand J Infect Dis       Date:  2010

8.  Memory T-cell responses to Vibrio cholerae O1 infection.

Authors:  Ana A Weil; Mohammad Arifuzzaman; Taufiqur R Bhuiyan; Regina C LaRocque; Aaron M Harris; Emily A Kendall; Azim Hossain; Abdullah A Tarique; Alaullah Sheikh; Fahima Chowdhury; Ashraful I Khan; Farhan Murshed; Kenneth C Parker; Kalyan K Banerjee; Edward T Ryan; Jason B Harris; Firdausi Qadri; Stephen B Calderwood
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

Review 9.  Critical analysis of compositions and protective efficacies of oral killed cholera vaccines.

Authors:  Shahjahan Kabir
Journal:  Clin Vaccine Immunol       Date:  2014-07-23

10.  Expression of toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum).

Authors:  Manoj Kumar Sharma; Nirmal Kumar Singh; Dewal Jani; Rama Sisodia; M Thungapathra; J K Gautam; L S Meena; Yogendra Singh; Amit Ghosh; Akhilesh Kumar Tyagi; Arun Kumar Sharma
Journal:  Plant Cell Rep       Date:  2007-10-26       Impact factor: 4.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.